Functional eye conditions—from amblyopia and strabismus to the escalating global burden of myopia—are putting unprecedented pressure on ophthalmology and optometry practices. Clinics need tools that can extend care beyond the chair, improve patient compliance, and generate measurable outcomes. Guangzhou Shijing Medical Software Co., Ltd. has been answering that need since 2008 with digital diagnosis and treatment platforms that combine artificial intelligence, image analysis, and virtual reality. Today, the company’s solutions are used in more than 3,000 eye hospitals and optometry centers across China, as well as in home therapy settings, with cumulative use exceeding 500,000 patients.
For overseas distributors, clinic groups, and eye care providers, Shijing Medical offers a rare combination: a mature digital therapeutics portfolio, deep clinical relationships, and a research pipeline focused on the full lifecycle of functional eye disease. This article outlines the company’s core products, clinical evidence, application scenarios, and partnership opportunities.
A Focused Innovator in Ophthalmology and Optometry
Founded in 2008, Shijing Medical is a medical technology company dedicated to innovation in ophthalmology and optometry. The company’s mission is to become a leader in full-lifecycle functional eye disease solutions. Its R&D team focuses on frontier technologies including artificial intelligence, image analysis, and virtual reality—technologies that are reshaping how visual function is assessed, trained, and monitored.
That focus has produced a portfolio of more than 200 intellectual property assets, including more than 60 authorized invention patents. Shijing Medical has also received provincial key R&D project approvals and collaborates with well-known medical institutions in China on clinical trials and research programs. These collaborations help translate laboratory innovation into practical tools that clinicians can trust.
Two Core Platforms: DOBOSO and BaBy Blissful
DOBOSO is Shijing Medical’s digital diagnosis and treatment solution for visual function training. It is designed to support the assessment and training of visual function through engaging, technology-assisted protocols. By combining VR-based training with digital treatment management, DOBOSO helps clinics deliver structured therapy that patients can continue at home. For providers, the platform supports better workflow efficiency and consistent delivery; for patients and parents, it offers a more engaging and accessible therapy experience.
The solution is particularly relevant for pediatric eye care, where attention and compliance are critical. VR-based training can make repetitive visual exercises more engaging, while digital treatment data can help clinicians track progress. DOBOSO is used across hospitals, optometry centers, and home therapy scenarios, making it a flexible option for partners who need to serve patients across different care settings.
BaBy Blissful is Shijing Medical’s PBM photobiomodulation digital diagnosis and treatment solution. Photobiomodulation is a non-invasive light-based approach that is gaining attention in eye care for its potential to support ocular health and complement existing therapies. BaBy Blissful brings digital treatment management to PBM, helping clinicians deliver and track therapy in a controlled, repeatable way. As part of a broader functional eye care strategy, it expands the options available to clinics that want to offer patients non-invasive, technology-enabled care.
Clinical Adoption and Real-World Impact
Shijing Medical’s products are widely deployed across China’s eye care system. More than 3,000 eye hospitals and optometry centers use its solutions, and cumulative use has surpassed 500,000 people. The company reports consistent positive feedback from clinicians and patients’ parents, and its market share in comparable product categories remains a leading position in the industry.
That adoption matters for international partners. It means the platforms have been tested in high-volume clinical environments, where reliability, usability, and patient engagement are essential. It also means Shijing Medical understands the operational realities of eye care providers—from busy outpatient departments to community optometry chains and home-based therapy programs.
Research, Standards, and Industry Leadership
Shijing Medical invests continuously in R&D and industry standardization. The company has led or participated in the development of multiple team and industry standards, including the Technical and Application Specification for VR Visual Training Systems. Standards work is not a marketing afterthought; it is part of the company’s commitment to quality, safety, and interoperability in digital eye care.
The company has also co-published major industry research with Frost & Sullivan and MedSci, including the 2026 Blue Book on the Current Status and Future Trends of Myopia Management for Children and Adolescents, the Blue Book on the Current Status of Digital Treatment for Amblyopia and Strabismus in Chinese Children, and the related white paper. These reports help clinicians, policymakers, and industry partners understand the evolving landscape of pediatric eye care and the role of digital therapeutics.
Recognition includes listing on the Guangzhou Pre-IPO High-Tech Enterprise Reserve Top 100, selection for the Deloitte China Rising Star list, and awards such as China Digital Therapeutics Top 10, the Global Ophthalmology Clinical Application Award, and China Visual Function Training Leading Brand. These honors reflect the company’s standing in the Chinese digital therapeutics ecosystem and its focus on clinical application.
Application Scenarios for Overseas Partners
Shijing Medical’s platforms are relevant to a wide range of eye care settings. Hospitals and eye clinics can use DOBOSO and BaBy Blissful to expand their functional eye care services, support pediatric patients, and offer structured home therapy programs. Optometry chains and vision centers can integrate digital visual function training into myopia management and visual function services. Home therapy programs benefit from engaging VR content and digital monitoring that help patients stay on track between clinic visits.
For distributors, the portfolio offers multiple entry points: a digital visual function training platform, a PBM photobiomodulation solution, and a company with the research depth to support clinician education and market development. Partners can position Shijing Medical as a premium, evidence-informed brand for functional eye care rather than a commodity device supplier.
Why the Global Market Is Moving Toward Digital Eye Care
The global eye care market is under strain. Myopia prevalence is rising, especially among children and adolescents. Amblyopia and strabismus continue to require long-term management. At the same time, many regions face a shortage of pediatric ophthalmologists and trained orthoptists. Digital therapeutics can help bridge that gap by standardizing therapy, supporting patient monitoring, and enabling patients to continue training at home.
But digital tools only earn clinician trust when they are backed by research, standards, and real-world adoption. Shijing Medical’s combination of patents, clinical collaborations, industry standards, and large-scale deployment positions it well for partners who want to bring credible digital eye care solutions to their markets. The company’s focus on the full lifecycle of functional eye disease—from early detection and diagnosis to training, treatment, and long-term management—aligns with the way modern eye care is evolving.
Partner With Shijing Medical
Shijing Medical welcomes overseas distributors, clinic groups, and strategic partners who share its commitment to improving functional eye care. Whether you are building a pediatric myopia management program, expanding visual function training services, or adding non-invasive PBM therapy to your portfolio, the company offers a mature platform and a collaborative approach to market development.
To learn more about DOBOSO, BaBy Blissful, and partnership opportunities, visit www.shijingmed.com. The company’s team can provide product information and discuss how its digital therapeutics portfolio can fit your market.
Contact
Website: www.shijingmed.com
